In the competitive field of Nucleic Acids, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Nucleic Acids technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Nucleic Acids industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Nucleic Acids industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Nucleic Acids industry

EP4104687Compositions And Methods For Synthesizing 5 -Capped RnasTRILINK BIOTECHNOLOGIES, LLCOct 30, 2024COHAUSZ & FLORACK PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3517134Adeno-Associated Virus (Aav) Serotype 8 Sequences, Vectors Containing Same And Uses ThereforTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAOct 16, 2024STRAWMAN LIMITED
EP3227447Guide Rna With Chemical ModificationsAGILENT TECHNOLOGIES, INC.Sep 23, 2024JAMES POOLE LIMITED
EP3906789Compositions And Methods For Synthesizing 5 -Capped RnasTRILINK BIOTECHNOLOGIES, LLCAug 22, 2024COHAUSZ & FLORACK PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3954225Compositions And Methods For Synthesizing 5'-Capped RnasTRILINK BIOTECHNOLOGIES, LLCAug 22, 2024COHAUSZ & FLORACK PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3870594Process For The Purification Of OligonucleotidesF. HOFFMANN-LA ROCHE AGMay 2, 2024CYTIVA SWEDEN AB
EP4140491Compositions And Methods For Synthesizing 5'-Capped RnasTRILINK BIOTECHNOLOGIES, LLCApr 12, 2024COHAUSZ & FLORACK PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP2877854Fusion Proteins And Methods ThereofTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKJun 7, 2023BOULT WADE TENNANT LLP
EP3122870Methods And Genetic Systems For Cell EngineeringGINKGO BIOWORKS INC.Mar 29, 2023MARKS & CLERK LLP
EP3122870Methods And Genetic Systems For Cell EngineeringGINKGO BIOWORKS INC.Mar 28, 2023POTTER CLARKSON LLP

To stay ahead in the competitive Nucleic Acids industry, companies are constantly innovating. Here are the top patents facing oppositions in the Nucleic Acids industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3682905Dec 1, 2021Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNATX, INC.10
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX, INC.10
EP3590949May 18, 2022Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNATX, INC.9
EP3214091Oct 3, 2018Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA4
EP2258847Jul 1, 2020Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICS AG3
EP1234031Nov 24, 2021B7-H1, A Novel Immunoregulatory MoleculeMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH3
EP1857547Dec 2, 2020Further Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICS GMBH3
EP2279254Jul 5, 2017Novel Lipid Formulations For Nucleic Acid DeliveryARBUTUS BIOPHARMA CORPORATION2
EP2423331May 8, 2019Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting TreatmentsTHE GENERAL HOSPITAL CORPORATION2
EP2325644Jul 29, 2020Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type XiiBECTON DICKINSON INFUSION THERAPY SYSTEMS INC.2